Navigation Links
The first International Sigma Anti-Bonding Calcium Symposium (ISACS 2019) by CBHI
Date:10/10/2019

Calcium & Bone Health Institute (CBHI) held International Sigma Anti-Bonding Calcium Symposium (ISACS) 2019 at Executive Plaza Hotel in Vancouver, Canada on September 23-24 for two days. The purpose of symposium was to discuss and share the knowledge of the various measures to develop healthy bone and to prevent calcium-related diseases. The theme of this year was “The Secret of Reversible Bone Health”.

“While serving as the president of CBHI which conducts intensive research about the significance of calcium for the human body, I thought of a place where researchers and professors come together to share their knowledge and create synergy effect in their research field,” said Dr. Paul Lee, the ISACS Chair. “I am very grateful that we could start the first Symposium in Vancouver, Canada. I hope more people be aware of the importance of bone health and the available solutions for their bodies.”

The speakers included researchers, professors, dentists, pharmacists, businessmen and patients. People from U.S.A., Canada, Korea, China, Indonesia, and Japan attended in the event. The topics by speakers ranged from cancer, bone, dental treatment, and arrhythmias, to diabetes. Testimonials by patients with SAC treatment were also presented.

SAC (Sigma Anti-Bonding Calcium) calcium was invented by Dr. Paul Lee in 2009. The atomic orbitals of SAC calcium molecule have sigma anti-bonding and therefore, easily separated into atoms in the water, absorbed in the body in the ionic form, Ca++. It is 200 times more soluble in water and has shown up to 80% bone mineral density increase in thousands of people. SAC calcium awakens body’s dormant response and the process is fully natural without side effect.

As the first ISACS 2019 was successfully held, CBHI plans to hold the event internationally following years.

About CBHI
Calcium and Bone Health Institute (CBHI) is Canada based research organization that has invented Sigma Anti-bonding Calcium (SAC). It has partnership with many universities and research organizations. Its invented SAC calcium was tried by thousands of people with great responses from their bodies. It continues to research on many challenging diseases such as osteoporosis, cancer, stem cell, diabetes, Alzheimer’s disease and more.

Read the full story at https://www.prweb.com/releases/the_first_international_sigma_anti_bonding_calcium_symposium_isacs_2019_by_cbhi/prweb16627357.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Aware, Inc. Reports First Quarter 2013 Financial Results
2. Odd experiments by Americas first physiologist shed light on digestion
3. CNIO researchers capture the replication of the human genome for the first time
4. European support for the first network of research and training in political ecology
5. Bowman Design Group is first US company awarded German FAMAB Sustainable Company certification
6. First Atlanta Science Festival set for 2014
7. Gym class reduces probability of obesity, study finds for first time
8. First successful treatment of pediatric cerebral palsy with autologous cord blood
9. Emory, Georgia Tech receive first human exposome center grant in US
10. Thermal limit for animal life redefined by first lab study of deep-sea vent worms
11. First dual-action compound kills cancer cells, stops them from spreading
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2019)... ... October 10, 2019 , ... ... ultrasound, invites attendees of the American Society of Anesthesiologists 2019 Annual Meeting to ... on October 19-21 in Orlando, Florida, and will provide more than 14,000 healthcare ...
(Date:10/8/2019)... (PRWEB) , ... October 07, 2019 , ... The future ... to the genetic level, resulting in people living longer, healthier lives. But it will ... on earth. , Leroy E. Hood, MD, PhD, Chief Strategy Officer and Co-Founder of ...
(Date:10/3/2019)... ... October 02, 2019 , ... Personalized Stem Cells, ... patient in an FDA approved clinical trial for stem cell treatment of knee ... formation of the company as a subsidiary of VetStem Biopharma. , PSC CEO, Michael ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... , ... October 09, 2019 , ... ... Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for ... 2019 in Las Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative ...
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has ... October 18-19th, 2019 in Las Vegas with spots still open. , The speaker, Dr. ... several Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as the ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... Madhumita Suresh and Leslie Maurer presented company executives with a set of recommendations ... (MBS) graduates will offer insights from their TMP to a wider audience of ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell biotechnology company ... technology. Like the company’s precursor patent, approved in the U.S. in 2017, the ... stem cells. Asymmetrex now markets the technology in the U.S. as the AlphaSTEM ...
Breaking Biology Technology: